CHICAGO , Aug. 30, 2022 /PRNewswire/ -- Medical Ceramics Market is projected to grow from USD 2.6 billion in 2022 to USD 3.6 billion by 2027, at a CAGR of 6.6% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth of the global market can be attributed to factors such as increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries & wound healing applications; the rising number of hip & knee replacement procedures.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237425129
Browse in-depth TOC on "Medical Ceramics Market"
The zirconia segment accounted for the largest share of the bioinert ceramics market, by type, in 2021
By type, the global bioinert ceramics market is segmented into zirconia, alumina, and other bioinert ceramics (titanium, pyrolytic carbon, and silicon nitride). In 2021, the zirconia segment dominated the global bioinert ceramics market. The advantages of zirconia over other ceramic materials, the increasing demand for aesthetically attractive dental restorations are the major driving factors for this market.
Dental applications segment is anticipated to hold major share of the global medical ceramics market in 2021
Based on application, the global medical ceramic market is segmented into dental applications, orthopedic applications, surgical instruments, and plastic surgery. The dental applications segment accounted for the largest share of the market in 2021. This segments large share can be attributed to the increasing number of cosmetic dental procedures and dental implant procedures across various regions and rising periodontal disorders.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=237425129
North America to hold a significant share of the medical ceramics market during the forecast period
The medical ceramic market is segmented into five regional segments, namely, North America , Europe , Asia Pacific , Latin America , and Middle East & Africa . The North American region accounted for the largest share of the market in 2021. This can be attributed to the aging population, increasing number of heart diseases, growing demand for plastic surgeries, technological advancements, and the growing number of trained professionals in the region.
The major players operating in the medical ceramics market are CeramTec GmbH (Germany ), KYOCERA Corporation (Japan ), Morgan Advanced Materials (UK), Nobel Biocare Services (Switzerland ), Tosoh Corporation (Japan ), Institut Straumann (Switzerland ), 3M (US), Royal DSM (DSM) (Netherlands ), Elan Technology (US), Bakony Technical Ceramic Ltd. (Hungary ), Superior Technical Ceramics (US), QSIL Ceramics GmbH (Germany ), NGK Spark Plug (Japan ), CoorsTek, Inc. (US), BCE Special Ceramics (Germany ), Advanced Ceramic Materials (US), Berkeley Advanced Biomaterials (US), Kuraray Noritake Dental (Japan ), Ferro Corporation (Japan ), Washington Mills (US), H.C. Stark GmbH (Germany ), CAM Bioceramics (The Netherlands ), CaP Biomaterials (US), and Berkeley Advanced Biomaterials (US).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=237425129
Browse Adjacent Market: Medical Devices Market Research Reports & Consulting
Dental Bone Graft Substitute Market by Type (Synthetic Bone Grafts, Xenograft, Allograft, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (Bio-OSS, OsteoGraf, Grafton ), End User (Hospital)- Global Forecast to 2025
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/medical-ceramic-market.asp Visit Our Website: https://www.marketsandmarkets.com/ Content Source: https://www.marketsandmarkets.com/PressReleases/medical-ceramic.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/medical-ceramics-market-worth-3-6-billion-by-2027--exclusive-report-by-marketsandmarkets-301614560.html
Nio (NYSE: NIO) reported increasing losses in its second-quarter earnings report this week, but investors are shrugging that off, sending shares soaring Friday morning. Although its profit margins have been on a downward trend, new models being launched could turn that around in the coming years. Consumer prices in China increased at a slower pace than many expected in August, and producer inflation sank to the lowest level since February 2021, reports Reuters.
As we close in on the final quarter of 2022, investors are looking for an answer to one question: was June’s low the bottom for stocks, or do they have more room to fall? It’s a serious question, and there may be no easy answer. Markets are facing a series of headwinds, from the high inflation and rising interest rates that we’ve grown familiar with to an increasingly strong dollar that will put pressure on the upcoming Q3 earnings. Weighing in on current conditions from Charles Schwab, the $8 t
Advanced Micro Devices, Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $AMD performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.
Berkshire Hathaway is on pace to collect $6.07 billion in dividend income over the next 12 months. Just five holdings will account for 71% of total payouts.
Canadian cannabis company Tilray Brands (NASDAQ: TLRY) hasn't been a great stock for shareholders over the last year, with shares down more than 70%. Part of the reason for that has been the lack of progress toward legalizing cannabis in the U.S. But Tilray has established a presence south of the Canadian border and has profitable beer and spirits businesses there. An expansion of one of those businesses had investors pushing Tilray stock 4.6% higher as of 12:40 p.m. ET Friday.
The S&P 500 is on again, off again all year. But investors clearly have a "buy list" of stocks they want to own when the rally looks real.
A strong bearish trend defined the markets in the first half of the year; since then, the key point has been volatility. Stocks hit a bottom back in June, when the S&P 500 dropped into the 3,600s. That has proven to be a support level in the last two months, and at least one strategist believes that the market won’t be testing those lows again this year. JPMorgan's Jason Hunter believes that inflation may have peaked, and that the upcoming CPI report will provide additional evidence of that. “We
Investors are seeing higher growth potential for QuantumScape's battery cell technology after an interesting EV industry development.
AT&T income-hungry shareholders should have seen it coming. In April last year, a month before announcing the spinoff of its media division to shareholders in the form of shares of a 71% stake in the newly created Warner Bros. Discovery Chief Executive Officer John Stankey assured investors that “our deliberate capital-allocation plan allowed us to invest and sustain our dividend at current levels, which we believe is attractive.” AT&T’s eventual failure to raise the dividend in 2021 broke a 34-year streak and saw it booted out of the vaunted S&P 500 Dividend Aristocrats Index.
On Friday, the company unveiled the Robinhood Investor Index, which captures how customers invest based on the top 100 most owned stocks on the platform.
Gary Gensler had strong words for the crypto industry in a Thursday speech, telling an audience of lawyers that the "vast majority" of the nearly 10,000 existing crypto tokens are securities.
Devon Energy (DVN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The old saying “different strokes for different folks” certainly rings true in the stock market. Some investors prefer growth stocks like Tesla Inc. that are volatile but have produced years of outstanding appreciation. Other folks prefer less volatile stocks like Johnson & Johnson whose growth may be slower but also add dividends of 2% to 3% annually to the total performance. In addition, there are income investors, who strictly look for stocks that will provide high-yield dividends year after
The Facebook and Instagram owner's share price zoomed more than 4% higher on Friday, as investors bid the company up on news that it had disbanded one of its teams. Thursday afternoon, The Wall Street Journal reported that Meta had dissolved the Responsible Innovation (RI) unit at the company. This was the team that kept an eye on the ethics of its products and services, which also include messaging app WhatsApp in addition to Facebook and Instagram.
In this article, we discuss 10 dividend stocks with over 8% yield to buy in September. You can skip our detailed analysis of top high dividend stocks, and go directly to read 5 Best Dividend Stocks with Over 8% Yield You Can Buy in September. In the current market situation, investors are looking for different […]
Fintech stocks were crushed during the market's decline this year. Thus, they tend bounce harder on recoveries.
Pinterest (PINS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wall Street firm BofA Securities on Friday identified seven semiconductor stocks that it believes can withstand the current market downturn.
ChargePoint Holdings (NYSE: CHPT) stock jumped this week, gaining a solid 21.6% through the week as of 1 p.m. ET Friday, according to data provided by S&P Global Market Intelligence. If ChargePoint impressed investors with its quarterly numbers and outlook last week, an analyst singled out the electric vehicle (EV) charging stock this week as a major potential winner from the Inflation Reduction Act (IRA). Maheep Mandloi from Credit Suisse initiated coverage on ChargePoint stock midweek with an outperform rating and a price target of $22 per share.
What's better than a big fat S&P 500 dividend? One that's rising fast. And there's a surprising number of S&P 500 stocks doing it.